SBIR / STTR #DPA26BZ06-DV025

DARPA SBIR Solicitation for Noninvasive Occult Hemorrhage Detection Device

DARPA, part of the Department of Defense, is seeking innovative solutions for noninvasive detection and localization of occult hemorrhage, targeting battlefield and remote emergency medicine. - Government Buyer: - Defense Advanced Research Projects Agency (DARPA), Department of Defense - DARPA Small Business Programs Office, Contracts Management Office - OEMs and Vendors: - No specific OEMs or vendors are named; opportunity is open to technology developers and medical device manufacturers - Products/Services Requested: - Development of a portable, noninvasive or minimally invasive medical device integrating advanced sensing and AI for real-time detection, localization, and characterization of internal hemorrhage - Phase I: Proof-of-concept research and technical feasibility demonstration - Phase II: Prototype development, integration, and validation for clinical decision support - Device must support triage and evacuation decisions in austere environments - Unique/Notable Requirements: - Dual-use potential for military and civilian emergency response - Must operate in rugged, remote, and resource-limited settings - Emphasis on rapid, real-time detection and monitoring - Compliance with SBIR proposal guidelines and electronic submission - Award amounts range from $250,000 (Phase I) to $1.8 million (Phase II) - Periods of performance: 6 months (Phase I), 12-24 months (Phase II)

Description

This solicitation seeks the development of noninvasive methods for detecting and localizing occult hemorrhage. It is part of the DARPA SBIR Phase 1 program, focusing on innovative research concepts important to national security. Proposals must be submitted electronically through the DoW SBIR/STTR Innovation Portal by the specified deadline. The award amount for Phase I is $250,000 with a period of performance of 6 months.

View original listing